This Clinical Trial will Demonstrate the Use of TETRANITE ® to Reintegrate Cranial Bone Flaps for Improved Clinical Outcomes "The background scientific work coupled with the promising recruitment thus ...

This Clinical Trial will Show Preliminary Safety and Probable Benefit of TETRANITE ® for Replacing the Use of Metal Plates and Screws LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it ...

RevBio, Inc., announced that it has received investigational device exemption (IDE) approval from the FDA to conduct a multi-center randomized controlled pivotal clinical trial to use TETRANITE(R) to ...

US-based bone adhesive company RevBio has received approval from the US Food and Drug Administration (FDA) to expand an ongoing clinical trial of its bone adhesive biomaterial Tetranite. The agency ...

LOWELL, Mass., May 5, 2020 /PRNewswire/ -- LaunchPad Medical, Inc. announced that it has been awarded a $2.5 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant (1R44NS115386) ...

Researchers at Central South University and MedArt developed a biodegradable cranial fixation device that strengthens bone healing, reduces complications, and offers a safer alternative to traditional ...

DUBLIN--(BUSINESS WIRE)--The "Cranial Fixation & Stabilization Systems Market by Product (Screw, Mesh, Skullclamp, Horseshoe Headrest, Accessories, Adaptor, Arms ...

This Clinical Trial will Demonstrate the Use of TETRANITE to Reintegrate Cranial Bone Flaps for Improved Clinical Outcomes RevBio, Inc., announced that it has received approval from the Medicines and ...

RevBio, Inc., announced that it has received investigational device exemption (IDE) approval from the FDA to conduct a multi-center randomized controlled pivotal clinical trial to use TETRANITE® to ...

This clinical trial is designed to demonstrate that TETRANITE® can immediately fixate cranial flaps and enable bone fusion in craniotomy and cranioplasty procedures to improve cosmesis, increase flap ...